The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial
| dc.contributor.author | Gurleyik, G. | |
| dc.contributor.author | Cabioglu, Neslihan | |
| dc.contributor.author | Ugurlu, U. M. | |
| dc.contributor.author | Col, C. | |
| dc.contributor.author | Bozkurt, B. | |
| dc.contributor.author | Uzunkoy, A. | |
| dc.contributor.author | Sezgin, E. | |
| dc.contributor.author | Soran, A. | |
| dc.contributor.author | Muslumanoglu, M. | |
| dc.contributor.author | Karanlik, H. | |
| dc.contributor.author | Aksaz, E. | |
| dc.contributor.author | Uras, C. | |
| dc.contributor.author | Ozbas, S. | |
| dc.contributor.author | Igci, A. | |
| dc.contributor.author | Canturk, Z. | |
| dc.contributor.author | Utkan, Z. | |
| dc.contributor.author | Ozaslan, C. | |
| dc.contributor.author | Evrensel, T. | |
| dc.contributor.author | Ozmen, V. | |
| dc.contributor.author | Soyder, A. | |
| dc.date.accessioned | 2021-03-04T15:10:54Z | |
| dc.date.available | 2021-03-04T15:10:54Z | |
| dc.identifier.citation | Ozmen V., Ozbas S., Karanlik H., Muslumanoglu M., Igci A., Canturk Z., Utkan Z., Ozaslan C., Evrensel T., Uras C., et al., "The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial", 44th Congress of the European-Society-for-Medical-Oncology (ESMO), Barcelona, İspanya, 27 Eylül - 01 Ekim 2019, cilt.30 | |
| dc.identifier.other | av_8567ab24-87ed-4650-9b7d-62d0e336e82c | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/90711 | |
| dc.language.iso | eng | |
| dc.subject | Klinik Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Tıp | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | ONKOLOJİ | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Oncology | |
| dc.subject | Health Sciences | |
| dc.title | The importance of primary surgery in patients with de novo stage IV BC surviving at least 5 years: Protocol MF07-01 randomized clinical trial | |
| dc.type | Bildiri | |
| dc.contributor.department | MAMER , , | |
| dc.identifier.volume | 30 | |
| dc.contributor.firstauthorID | 157498 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]